European Archives - Page 229 of 1427 - European Medical Journal

Daily Moisturising in Infants Shown to Reduce Eczema Risk

Daily moisturising may prevent infant eczema, even in low-risk babies, offering a practical approach for early skin care.

BMS’ Emma Charles on access, impact and inclusion

Emma shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and fairer in Europe.

Expanding Treatment Horizons: Advancements in Key mCRC Populations

The following topics were covered during a symposium at the 2025 European Society for Medical Oncology Gastrointestinal Cancers (ESMO-GI)…

Does Early Cardiac Rehabilitation Improve Severe Acute Heart Failure?

Early cardiac rehabilitation did not improve function or rehospitalisation in severe heart failure, but mobility gains were seen.

Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford

Onc Now: Episode 23: From Lab to Life in Breast Cancer Care

How if scientific innovation transforming precision oncology? Simon Lord, Associate Professor in Experimental Cancer Therapeutics at the University of Oxford shares his expertise.

Treatment Advances for Muscle-Invasive Bladder Cancer

Despite aggressive interventions, the five-year survival rate remains below 50% for those with localised disease and plummets to less than 15% when metastasis occurs.

AI Model Improves Survival Prediction in Patients with Fibrotic Lung Disease

A new AI model shows promise in predicting survival in patients with fibrotic lung disease, offering more precise prognosis than standard tests and imaging methods.

Early MRI Predicts Immunotherapy Response in Triple-Negative Breast Cancer

New MRI model predicts early treatment response in TNBC, supporting faster, more tailored clinical decisions.

Maternal Depression Linked to Adolescent Brain Connectivity Changes

Prenatal maternal depression alters brain connectivity patterns in children through adolescence, new large-cohort study reveals.

Canagliflozin Shows Promise for Children with Type 2 Diabetes

Learn how canagliflozin safely improves glycaemic control in children with Type 2 diabetes.